BioCentury
ARTICLE | Clinical News

Xerecept corticorelin: Phase II data

June 8, 2009 7:00 AM UTC

Celtic Pharmaceutical Holdings L.P., Hamilton, Bermuda Neurobiological Technologies Inc. (NASDAQ:NTII), Emeryville, Calif. Product: Xerecept corticorelin Business: Cancer Molecular target: Corticot...